Mirae Asset Global Investments’s Verona Pharma VRNA Stock Holding History

Mirae Asset Global Investments’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,280	Closed	-$350K	–	1750
2025 Q3	$350K	Sell	3,280 -8,600	-72%	-$898K	﹤0.01%	1048
2025 Q2	$1.12M	Buy	11,880 +394	+3%	+$29.2K	﹤0.01%	807
2025 Q1	$720K	Buy	11,486 +9,021	+366%	+$540K	﹤0.01%	873
2024 Q4	$114K	Sell	2,465 -145	-6%	-$5.44K	﹤0.01%	1126
2024 Q3	$75.1K	Buy	2,610 +529	+25%	+$13K	﹤0.01%	1233
2024 Q2	$32.1K	Buy	+2,081	New	+$30.4K	﹤0.01%	1322

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Mirae Asset Global Investments's VRNA Position: Q4 2025 in Review

Mirae Asset Global Investments sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 3,280 shares — an estimated $350K sold.

Mirae Asset Global Investments first reported a position in VRNA in Q2 2024 and held it in 6 quarters. The position peaked at $1.12M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Mirae Asset Global Investments reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Mirae Asset Global Investments sold 3,280 Verona Pharma shares in Q4 2025, an estimated $350K.
Mirae Asset Global Investments first reported a position in Verona Pharma in Q2 2024 and held it in 6 quarters.
Mirae Asset Global Investments's Verona Pharma position peaked at $1.12M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.